Viome Life Sciences Overview

  • Founded

  • 2016

Founded
  • Status

  • Private

  • Employees

  • 160

Employees
  • Latest Deal Type

  • Series C

  • Latest Deal Amount

  • $67M

  • Investors

  • 20

Viome Life Sciences General Information

Description

Operator of a biotechnology and healthcare company intended to prevent and reverse chronic diseases. The company digitizes the human body and its microbiomes on a molecular level using at-home clinical-grade tests, analyzed through proprietary RNA sequencing technology, and decodes precise health insights and biomarkers of various chronic diseases using artificial intelligence and systems biology expertise, enabling healthcare providers to give personalized nutrition recommendations and precision supplements to their patients.

Contact Information

Website
www.viomelifesciences.com
Formerly Known As
Bluespin
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Information Services (B2C)
Primary Office
  • 205 108th Avenue Northeast
  • Suite 150
  • Bellevue, WA 98004
  • United States

Viome Life Sciences Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Viome Life Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series C) 11-Oct-2022 $67M 00000 00000 Completed Generating Revenue
5. Debt - General 01-Jan-2022 0000 00000 Completed Generating Revenue
4. Early Stage VC (Series B) 05-Nov-2019 000.00 00000 00000 Completed Generating Revenue
3. Early Stage VC 02-Aug-2018 0000 0000 00000 Completed Generating Revenue
2. Early Stage VC (Series A) 28-Jul-2017 $15M $21M 0000 Completed Generating Revenue
1. Corporate $6M $6M Completed Startup
To view Viome Life Sciences’s complete valuation and funding history, request access »

Viome Life Sciences Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C-1 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series C 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series B 5,464,040 $0.000010 $11.72 $11.72 1x $11.72 8.9%
Series A 6,490,069 $0.000010 $2.63 $2.63 1x $2.63 10.57%
To view Viome Life Sciences’s complete cap table history, request access »

Viome Life Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology and healthcare company intended to prevent and reverse chronic diseases. The company digitiz
Biotechnology
Bellevue, WA
160 As of 2022
00000
0000 0000-00-00
00000000000 00000

000000

por incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis n
0000000000000 000000
Chicago, IL
0000 As of 0000
00.000
00.00 0000-00-00
00000000000 00.000

000000

do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim
0000000000000
Seoul, South Korea
00 As of 0000
000.00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Viome Life Sciences Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Tempus Labs Venture Capital-Backed Chicago, IL 0000 00.000 00000000000 00.000
00000000 Formerly VC-backed Seoul, South Korea 00 000.00 00000000 000.00
000000 0000 000000 Private Equity-Backed South San Francisco, CA 0000 00.00 000000000000 00.00
000000000 Venture Capital-Backed San Diego, CA 00 00000 0000000000 0 00000
0000000 Formerly VC-backed Sunnyvale, CA 000 00.000 000000000 00.000
You’re viewing 5 of 5 competitors. Get the full list »

Viome Life Sciences Patents

  • 28

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 10

    Pending

  • 000

    Expiring in next 12 mo

Viome Life Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220248735-A1 Personalized nutritional supplements and methods of making Pending 31-Dec-2020 0000000000 0
US-20220344003-A1 Biomarkers for age Pending 04-Sep-2020 000000000
CA-3173672-A1 Diagnostic for oral cancer Pending 27-Mar-2020 000000000
EP-4127245-A2 Diagnostic for oral cancer Pending 27-Mar-2020 000000000
US-20230162858-A1 Diagnostic for oral cancer Pending 27-Mar-2020 G16H50/20
To view Viome Life Sciences’s complete patent history, request access »

Viome Life Sciences Executive Team (11)

Name Title Board Seat Contact Info
Naveen Jain Co-Founder, Chief Executive Officer & Board Member
John Blanchard Chief Operating Officer
Guruduth Banavar Co-Founder, Chief Technology Officer & Head of AI
Momchilo Vuyisich Co-Founder, Chief Scientific Officer & Head of Clinical Research
Stephen Barrie Ph.D Vice President & Head of Clinical Nutrition
You’re viewing 5 of 11 executive team members. Get the full list »

Viome Life Sciences Board Members (9)

Name Representing Role Since
Christopher Kitze Self Board Member 000 0000
Eiichiro Kimura Self Board Member 000 0000
Erik Anderson WestRiver Group Board Member 000 0000
Harish Consul Ocgrow Ventures Board Member 000 0000
Naveen Jain Viome Life Sciences Co-Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Viome Life Sciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Viome Life Sciences Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bulletproof Media Corporation Minority 000 0000 000000 0
Eastward Capital Partners Venture Capital Minority 000 0000 000000 0
Ezaki Glico Company Corporation Minority 000 0000 000000 0
Hambrecht Ducera Growth Ventures Venture Capital Minority 000 0000 000000 0
Milltrust International Asset Manager Minority 000 0000 000000 0
You’re viewing 5 of 20 investors. Get the full list »

Viome Life Sciences Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 (00000 06-Feb-2019 0000000000 Other Services (B2C Non-Financial) 000000 00
To view Viome Life Sciences’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Viome Life Sciences Subsidiaries (1)

Company Name Industry Location Founded
00000 (00000 00000 Other Services (B2C Non-Financial) Oakland, CA 0000
To view Viome Life Sciences’s complete subsidiaries history, request access »